Finance News – Gsk
What is your interest today?
Bitcoin
Crypto
Btc
Tariffs
Ceo
Cryptocurrency
Crypto Assets
Stocks
Investors
Stock
Shares
Stock Market
Ethereum
Markets
Price
Xrp
Investment
Blockchain
Sec
Stablecoin
Etf
Eth
Trade
Earnings
Revenue
Solana
Index
Bse
China
Ipo
Coinbase
Token
Wall Street
Nasdaq
Interest Rates
Inflation
Trade War
Usd
Economy
Tesla
Profit
Sensex
Digital Assets
Sp 500
Federal Reserve
Gold
Nvidia
Nse
Traders
Treasury
Families
Atom
Virtual Asset
Retirement Income
Goodfood
Increase
China Ai Market
Letters
House Bill 302
Fraud Convictions
= 1024) { setSearchBy('title'); suggestionOpen = true; fetch() }"
@input.debounce.300ms="window.innerWidth >= 1024 && fetch()"
@keydown.enter.prevent="window.innerWidth >= 1024 && submitSearch()"
placeholder="Search finance news…"
class="flex-grow bg-transparent border-0 focus:ring-0 px-4 py-2 placeholder-gray-500 dark:placeholder-gray-400 text-gray-900 dark:text-gray-100 mr-2"
/>
Filter by:
- ABC News Business
- BBC Business
- Business Insider Markets
- CBC Business
- City A.M.
- CNBC Business
- CoinDesk
- Cointelegraph
- Crypto News
- CryptoSlate
- Decrypt
- Economic Times Markets
- Euronews Business
- Financial Post Top Stories
- Financial Times
- Finextra Crypto
- Finextra Market
- Finextra Wealth
- Globe and Mail Investing
- Investing.com Global Markets
- Investing.com Global Mkts
- Investopedia
- Kiplinger
- MarketWatch MarketPulse
- MarketWatch Top Stories
- Quartz
- Sky News Money
- Sydney Morning Herald Biz
- Sydney Morning Herald Business
- TechCrunch Fintech
- The Block
- The Guardian – Business
- WSJ Markets News
City A.M. • May 12, 2025
GSK and Astrazeneca shares slump as Trump vows drug price cut
The announcement of new executive measures aimed at lowering medication costs has led to a decline in the stock values of major pharmaceutical companies, reflecting investor concer...
Read Full Article →
City A.M. • May 07, 2025
FTSE 100’s record run fades as pharma stocks slide on new Trump appointment
The decline in major pharmaceutical shares contributed to a modest drop in the FTSE 100, signaling potential market uncertainty linked to changes in US regulatory leadership.
Read Full Article →